Download Citation
Article Source:
A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection
Gardiner D,
Lalezari J,
Lawitz E,
DiMicco M,
Ghalib R,
et al.
(2013)
A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection.
PLOS ONE 8(5): e63818.
https://doi.org/10.1371/journal.pone.0063818